149 related articles for article (PubMed ID: 10641235)
1. Shigella Sonnei vaccine.
Drugs R D; 1999 Sep; 2(3):222-3. PubMed ID: 10641235
[No Abstract] [Full Text] [Related]
2. Clinical trials of Shigella vaccines in Israel.
Cohen D; Ashkenazi S; Green M; Gdalevich M; Yavzori M; Orr N; Robin G; Slepon R; Lerman Y; Block C; Ashkenazi I; Taylor D; Hale L; Sadoff J; Schneerson R; Robbins J; Wiener M; Shemer J
Adv Exp Med Biol; 1996; 397():159-67. PubMed ID: 8718595
[No Abstract] [Full Text] [Related]
3. Efficacy of a polyvalent protein-polysaccharide dysentery oral vaccine.
Zhang HM; Li YP; Song LH; Yu XL; Liu NH; Kong XE; Li L; Zhai YL
Chin Med J (Engl); 1987 May; 100(5):425-8. PubMed ID: 3115716
[No Abstract] [Full Text] [Related]
4. [Ribosomal dysentery vaccine. IV. Study of the reactogenicity, antigenic and protective activity of Shigella sonnei ribosomes in monkey experiments].
Dzhikidze EK; Kavtaradze KN; Levenson VI; Subbotina IuL; Fedosova VG
Zh Mikrobiol Epidemiol Immunobiol; 1981 Jul; (7):53-9. PubMed ID: 7025529
[No Abstract] [Full Text] [Related]
5. Successful field trials with oral killed Shigella sonnei vaccine.
Grahneis H
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):75-80. PubMed ID: 4613141
[No Abstract] [Full Text] [Related]
6. Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children.
Ashkenazi S; Passwell JH; Harlev E; Miron D; Dagan R; Farzan N; Ramon R; Majadly F; Bryla DA; Karpas AB; Robbins JB; Schneerson R
J Infect Dis; 1999 Jun; 179(6):1565-8. PubMed ID: 10228084
[TBL] [Abstract][Full Text] [Related]
7. [Humoral and cellular immunity in patients with acute dysentery].
Burkin AV; Kasimova NB; Galimzianova RM; Gor'kova AI; Shishkina SN
Ter Arkh; 1991; 63(11):22-5. PubMed ID: 1810054
[No Abstract] [Full Text] [Related]
8. [A study of the streptomycin-dependent mutants of shigella].
Sergeev VV; Taratorina OM; Elkina SI
Zh Mikrobiol Epidemiol Immunobiol; 1967 Sep; 44(9):28-32. PubMed ID: 4892079
[No Abstract] [Full Text] [Related]
9. [On the problem of specific prevention of dysentery. I. Selection of avirulent immunogenic strains of Flexner and Sonne dysentery bacteria].
Belaia IuA
Zh Mikrobiol Epidemiol Immunobiol; 1968 Apr; 45(4):14-9. PubMed ID: 4898256
[No Abstract] [Full Text] [Related]
10. [Comparative immunomorphological study of the immunogenic activity of dysentery vaccines produced by different methods].
Belaia IuA; Rukhamina ML; Nguyen ZH
Zh Mikrobiol Epidemiol Immunobiol; 1983 Jul; (7):64-70. PubMed ID: 6353818
[TBL] [Abstract][Full Text] [Related]
11. Prophylaxis of bacillary dysentery by liver vaccine Vadizen (Sh. flexneri T32-Istrati) in children collectivities in IS County.
Oană C; Buzdugan T; Constantiniu S; Cismaru M; Alexandru D; Dunea C; Funiac A; Radu M; Grumăzescu C; Meitert T
Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):331-5. PubMed ID: 6400307
[No Abstract] [Full Text] [Related]
12. Reduction of morbidity due to bacillary dysentery by live vaccine Vadizen (Sh. flexneri T32-Istrati) in children collectivities in BH County.
Pop C; Cernea L; Ciortea A; Ianossy L; Kallay T; Lugoş A; Meitert T; Ciudin L; Pencu E
Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):351-6. PubMed ID: 6400310
[No Abstract] [Full Text] [Related]
13. Specific immunoglobulin A-secreting cells in peripheral blood of humans following oral immunization with a bivalent Salmonella typhi-Shigella sonnei vaccine or infection by pathogenic S. sonnei.
Van de Verg L; Herrington DA; Murphy JR; Wasserman SS; Formal SB; Levine MM
Infect Immun; 1990 Jun; 58(6):2002-4. PubMed ID: 1692813
[TBL] [Abstract][Full Text] [Related]
14. Protection against local Shigella sonnei infection in mice by parenteral immunization with a nucleoprotein subcellular vaccine.
Levenson VJ; Mallett CP; Hale TL
Infect Immun; 1995 Jul; 63(7):2762-5. PubMed ID: 7790095
[TBL] [Abstract][Full Text] [Related]
15. [Specific disappearance of macrophages from the peritoneal exudate of guinea pigs following administration of Sh. sonnei endotoxin].
Solov'eva OG; Korneeva SA
Zh Mikrobiol Epidemiol Immunobiol; 1980; (2):62-6. PubMed ID: 6994415
[No Abstract] [Full Text] [Related]
16. [Trial of the protective activity of ribosomal Sonne vaccine in monkeys].
Levenson VI; Dzhikidze EK; Stasilevich ZK; Kavtaradze KN; Subbotina IuL
Vestn Akad Med Nauk SSSR; 1986; (3):69-72. PubMed ID: 3518271
[No Abstract] [Full Text] [Related]
17. Future needs and directions for Shigella vaccines.
Wkly Epidemiol Rec; 2006 Feb; 81(6):51-8. PubMed ID: 16673461
[No Abstract] [Full Text] [Related]
18. Laboratory control of oral Shigella sonnei vaccine.
Starke G; Thilo W
Prog Immunobiol Stand; 1970; 4():363-7. PubMed ID: 4921390
[No Abstract] [Full Text] [Related]
19. [Live shigella flexneri 2a and shigella sonnei vaccines (author's transl)].
Belaia IuA; Gekker VD; Kuz'min SN; Sergeeva NS
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):63-9. PubMed ID: 4216253
[No Abstract] [Full Text] [Related]
20. An outbreak of Sonne shigellosis in a population receiving oral attenuated shigella vaccines.
Levine MM; Rice PA; Gangarosa EJ; Morris GK; Snyder MJ; Formal SB; Wells JG; Gemski P; Hammond J
Am J Epidemiol; 1974 Jan; 99(1):30-6. PubMed ID: 4590191
[No Abstract] [Full Text] [Related]
[Next] [New Search]
